United State

English

MedCity News

MedCity News

About: MedCity News is the leading online news source for the business of innovation in healthcare. We offer insight into what’s next and what matters with a mix of breaking news and analysis on startups, and established industry leaders, personalities, policies and the most important deals.
Contact Us: Email: breakingmedia@theygsgroup.com
How Philips Uses Monitoring Tech to Help Close Care Access Gaps

How Philips Uses Monitoring Tech to Help Close Care Access Gaps

Amae Health Raises $25M to Improve Care for Severe Mental Illness

Amae Health Raises $25M to Improve Care for Severe Mental Illness

Pfizer’s Sweeter $10B Offer Beats Novo Nordisk in Bidding War for Obesity Biotech Metsera

Pfizer’s Sweeter $10B Offer Beats Novo Nordisk in Bidding War for Obesity Biotech Metsera

Stronger Data Governance and Reliability Standards Needed for Wearables to Power Tech

Stronger Data Governance and Reliability Standards Needed for Wearables to Power Tech

More Than Meets the Eye: Using Eye Movements in Drug Development for Neurodegenerative Diseases

More Than Meets the Eye: Using Eye Movements in Drug Development for Neurodegenerative Diseases

Carrum Health Expands SUD Treatment Program to Include Nearly All Substances

Carrum Health Expands SUD Treatment Program to Include Nearly All Substances

FDA Adds 6 More Meds to Pilot Program for Speedy Review of Drugs in the National Interest

FDA Adds 6 More Meds to Pilot Program for Speedy Review of Drugs in the National Interest

How One Company Aims to Fix the Prosthetic Fitting Process

How One Company Aims to Fix the Prosthetic Fitting Process

MedCity FemFwd: Inside Wellcome Leap and Pivotal's $100M Commitment To Women's Health

MedCity FemFwd: Inside Wellcome Leap and Pivotal's $100M Commitment To Women's Health

StartUPDATES: New Developments from Healthcare Startups

StartUPDATES: New Developments from Healthcare Startups

Reimbursing Your Digital Twin: A New Era In Patient

Reimbursing Your Digital Twin: A New Era In Patient

Optimizing Care Pathways: The Next Frontier in Rehab Performance

Optimizing Care Pathways: The Next Frontier in Rehab Performance

Cigna’s Rebate-Free Model Sounds Nice, But Experts Are Still Skeptical

Cigna’s Rebate-Free Model Sounds Nice, But Experts Are Still Skeptical

Braveheart Bio Bags $185M for Drug That Could Rival a Bristol Myers Squibb Cardio Med

Braveheart Bio Bags $185M for Drug That Could Rival a Bristol Myers Squibb Cardio Med

Heard at HTH: Healthcare Executives Share New Products, Strategies, Outlook

Heard at HTH: Healthcare Executives Share New Products, Strategies, Outlook

Debunked Episode 21: The Drug Price Debate, AI in Healthcare Companies Face Consolidation But How Much?

Debunked Episode 21: The Drug Price Debate, AI in Healthcare Companies Face Consolidation But How Much?

Leveraging AI and LLMs To Close Critical Gaps in Patient Data and Transform Patient Risk Assessment in the ICU

Leveraging AI and LLMs To Close Critical Gaps in Patient Data and Transform Patient Risk Assessment in the ICU

Exploring How Ear-Based Stimulation May Support Stress Recovery and Post

Exploring How Ear-Based Stimulation May Support Stress Recovery and Post

As Healthcare and Biopharma Companies Embrace AI, Insurance Underwriters See Risks and Opportunities

As Healthcare and Biopharma Companies Embrace AI, Insurance Underwriters See Risks and Opportunities

Why ‘Time-to-Value’ Is the #1 Metric Healthcare AI Customers Care About

Why ‘Time-to-Value’ Is the #1 Metric Healthcare AI Customers Care About

UHC Taps Aeroflow Health for Virtual Nutrition Services

UHC Taps Aeroflow Health for Virtual Nutrition Services

UCB Drug Becomes First FDA-Approved Treatment for Ultra-Rare and Fatal Mitochondrial Disease

UCB Drug Becomes First FDA-Approved Treatment for Ultra-Rare and Fatal Mitochondrial Disease

Oncologists Turn To Genomics For Improved Answers

Oncologists Turn To Genomics For Improved Answers

The Future of Specialty Care: APPs, MDs, and Machine

The Future of Specialty Care: APPs, MDs, and Machine

Is Mark Cuban Wrong About Employers, PBMs and Drug Prices?

Is Mark Cuban Wrong About Employers, PBMs and Drug Prices?

Nearly 40,000 People Urge Employers to Cover Comprehensive Obesity Care

Nearly 40,000 People Urge Employers to Cover Comprehensive Obesity Care

Despite Phase 3 Failure, Sarepta Still Sees Path for Muscle Disease Drugs to Secure Full FDA Approval

Despite Phase 3 Failure, Sarepta Still Sees Path for Muscle Disease Drugs to Secure Full FDA Approval

Medtronic Exec: AI Is Improving Device Launches & Patient Outcomes

Medtronic Exec: AI Is Improving Device Launches & Patient Outcomes

Therapy 2.0: An AI-Powered Science of Language Intervention

Therapy 2.0: An AI-Powered Science of Language Intervention

The Critical Role Payers Can Play in Closing the Oral Health Gap

The Critical Role Payers Can Play in Closing the Oral Health Gap